Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS other · 2018-07-12

Clinical Trial Update: Clinical Trial of Pregabalin and COX2 in Spinal Stenosis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating pregabalin with a COX-2 inhibitor for lumbar spinal stenosis; current status is not disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Celecoxib (Celecoxib)
  • Pregabalin (Pregabalin)

Snippet

Sponsor: Seoul National University Bundang Hospital | Conditions: Spinal Stenosis Lumbar | Phase 4 | Status: UNKNOWN